Effects of ghrelin administration after total gastrectomy in patients with gastric cancer: A prospective randomized placebo-controlled phase II study
Phase 2
- Conditions
- Gastric cancer patients who underwent total gastrectomy.
- Registration Number
- JPRN-UMIN000001925
- Lead Sponsor
- Osaka University School of Medicine Gastroenterological Surgery
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
The exclusion criteria were the presence of any of the following; 1) cardiopulmonary, liver or renal dysfunction, 2) active dual malignancy, 3) pregnancy, 4) past history of gastrointestinal surgery, 5) postoperative complications after TG that could affect oral food intake, such as anastomotic leakage, pancreatitis and ileus.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Food intake calories (during 10-days ghrelin administration)
- Secondary Outcome Measures
Name Time Method appetite VAS, postoperative body weight, postoperative BMI (during 10-days ghrelin administration)